and bicycle ergometer stress testing. According to the ABPM patients were divided in three different blood pressure groups and the number of end-organ damages was evaluated for each blood pressure level. We observed a linear relationship between the number of end-organ damages and the level of blood pressure (Table 1) . Moreover, our data demonstrate that even in the group of patients with normal blood pressure a considerable percentage of end-organ damages were observed. ABPM seemed to be closely related to the number of end organ damages and may be useful as a prognostic parameter in hypertensive patients. The accepted level of normal blood pressure in ABPM may be even too high, as a considerable amount of patients exhibited endorgan damage even in the normal blood pressure range. Increased BP transmission to glomerular capillaries (1 P GC ) is postulated to play a major role in the pathogenesis of glomerulosclerosis (GS) and progressive renal disease. However, the exceedingly slow development of GS in rats with streptozotocin induced diabetes (STZ-DM; ϳ12-16 months) as compared to even a normotensive model of 3/4 renal mass reduction by surgical excision (RK-NX; ϳ4 months) has remained unexplained by conventional tail-cuff BP or P GC measurements and is at odds with the additional pathogenetic derangements operative in STZ diabetes (1 TGF-␤, 1 end-glycation products, 1 matrix production and 2 degradation). Because isolated tail-cuff BP may not reflect the ambient BP profiles, BP was radiotelemetrically (Data Sciences) measured at 10 min. intervals in control (nϭ11), partially insulin treated STZ-DM (nϭ11, blood glucose 300 -400 mg/dl) and RK-NX (nϭ5) rats. Systolic BP averages over a period of 4 -10 months were: control 124Ϯ1.6; STZ-DM 117Ϯ1.3; RK-NX 137Ϯ5.4; p Ͻ 0.05 vs each other. Additionally, BP was sampled at Ն 20Hz for 24 hrs for power spectral analysis (1-5 times/rat over the course). The power density for the different frequency bands was estimated using standard Fourier Transform methods.
Increased BP transmission to glomerular capillaries (1 P GC ) is postulated to play a major role in the pathogenesis of glomerulosclerosis (GS) and progressive renal disease. However, the exceedingly slow development of GS in rats with streptozotocin induced diabetes (STZ-DM; ϳ12-16 months) as compared to even a normotensive model of 3/4 renal mass reduction by surgical excision (RK-NX; ϳ4 months) has remained unexplained by conventional tail-cuff BP or P GC measurements and is at odds with the additional pathogenetic derangements operative in STZ diabetes (1 TGF-␤, 1 end-glycation products, 1 matrix production and 2 degradation). Because isolated tail-cuff BP may not reflect the ambient BP profiles, BP was radiotelemetrically (Data Sciences) measured at 10 min. intervals in control (nϭ11), partially insulin treated STZ-DM (nϭ11, blood glucose 300 -400 mg/dl) and RK-NX (nϭ5) rats. Systolic BP averages over a period of 4 -10 months were: control 124Ϯ1.6; STZ-DM 117Ϯ1.3; RK-NX 137Ϯ5.4; p Ͻ 0.05 vs each other. Additionally, BP was sampled at Ն 20Hz for 24 hrs for power spectral analysis (1-5 times/rat over the course). The power density for the different frequency bands was estimated using standard Fourier Transform methods.
These data indicate that contrary to the reported increase in tail-cuff BP, STZ-DM is associated with a decreased total pressure power due to both a lower BP, and a reduced BP variability. These effects may counteract the combined deleterious effects of the other pathogenetic derangements in diabetes and probably account for the markedly delayed development of GS in this model. Tachycardia has been proposed as an independent risk factor in arterial hypertension. The risk profile of hypertensives with nocturnal tachycardia has not been elucidated. To this end, we studied 485 untreated patients with essential hypertension and normal thyroid function. On 24h ambulatory blood pressure, nocturnal tachycardia (NT) with nighttime heart rate fall Ͻ0 bpm had 165 patients and nocturnal bradycardia with nighttime heart rate fall Ͼ20 bpm had 320 patients. Diastolic ambulatory and office blood pressure (BP) did not differ between groups (pϭNS). NT patients were more often diabetics (16.4 vs. 7.8%, pϭ.004) with central obesity (61.8 vs. 48.4%, pϭ.005) and non-dippers (57.6 vs. 22.8%, pϽ.00001). On echocardiographic examination, NT was associated with increased LV mass index (145 vs. 137 g/m 2 , pϭ.0005), LV systolic wall stress (76 vs. 69 dyne/ cm 2 , pϭ.00005) and aortic root stiffness (11.4 vs. 9.2, pϭ.0001). Of the biochemical markers, NT patients had higher triglycerides (134 vs. 118 mg/dL, pϭ.01) and lower HDL cholesterol (45.9 vs. 48.4 mg/dL, pϭ.04), higher total fibrinogen (306 vs. 289 mg/dL, pϭ.01) and plasminogen activator inhibitor 1 (2.85 vs. 2.31 IU/lt, pϭ.0002). Kidney function indices and plasma renin activity had similar values, although NT patients had higher serum uric acid (5.58 vs. 4.96 mg/dL, pϽ.00001).
It is concluded that hypertensives with NT is a high risk subgroup, with an accumulation of cardiovascular risk factors. 
